Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Data Sinergitama Jaya Tbk. (ELIT) vs UBC Medical Indonesia Tbk. (LABS)

Data Sinergitama Jaya Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Data Sinergitama Jaya Tbk. dan UBC Medical Indonesia Tbk.: Data Sinergitama Jaya Tbk. diperdagangkan di Rp171 (kapitalisasi pasar 347,41 M, volume 24 jam 2,44 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 641,4 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Data Sinergitama Jaya Tbk. lebih aktif diperdagangkan (2,44 jt vs 641,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

ELITLABS
Kapitalisasi Pasar
347,41 M635,95 M
Volume
2,44 jt641,4 rb
Lot
24,43 rb6,41 rb
Perputaran
417,39 jt104,5 jt
Harga Rata-rata
170,85162,93
Nilai Transaksi
417,39 jt104,5 jt
Harga Ekuilibrium Indikatif
172163
Volume Ekuilibrium Indikatif
8216

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ELIT
Lihat detail
LABS
Lihat detail

Tentang Data Sinergitama Jaya Tbk.

PT Data Sinergitama Jaya Tbk (the “Company”) was established based on Notarial Deed No. 38dated June 20, 2011 of Dana Sasmita, S.H., notary in Jakarta. The Company’s immediate and ultimate holding company is PT Gratus Deo Indonesia, a company incorporated in Indonesia.

Selengkapnya di halaman ELIT

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS